This study is not affiliated with PCOS Challenge, Inc.
The announcement below is being provided for informational purposes only.

PCOS Weight Loss Study Recruiting in the
Baton Rouge, LA Area*

Compensation Up to $200
See Below for Details and Eligibility Criteria

Woman’s Hospital

100 Woman’s Way, Baton Rouge, LA 70817

Study Title

A Randomized Placebo-Controlled Double Blind Trial of Liraglutide 3mg [Saxenda] on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women with Polycystic Ovary Syndrome

Study Description

Obesity plays a central role in the development of Polycystic Ovary Syndrome (PCOS), and exacerbates reproductive and metabolic dysfunction. Evidence suggests that medical treatment using drugs that manage obesity may modify the physiological and behavioral processes that contribute to weight gain and hinder weight loss.

The PCOS weight loss study is looking to see if the FDA-approved weight loss drug Saxenda is effective in reducing body weight and excessive male hormones in obese women with PCOS.

Goals of the Study

The goals of the study are to determine how Saxenda^® treatment impacts:

• Body weight
• Free androgen levels
• Menstrual cyclicity
• Glucose regulation
• Insulin sensitivity and secretion
• Body composition
• Cardiometabolic markers (lipids, blood pressure)

Eligibility Criteria

• Female
• Age 18-45
• Body Mass Index (BMI) of greater than 30
• Diagnosed with PCOS by hyperandrogenism (elevated male hormone or excess facial hair) and irregular menstrual cyclicity (less than 8 cycles/year)
• Non-diabetic
• Willing to use effective non-hormonal contraception consistently for the study duration

Eligible participants will be randomly assigned to the study drug or placebo in a 2:1 ratio (2 study drug:1 placebo)

Exclusions

• Any hepatic (liver) disease
• Eating disorder
• Renal (Kidney) Impairment
• Untreated thyroid disease
• Elevated triglyceride levels over 400 (or extremely elevated levels)
• Use of hormonal medications
• Active or prior history of substance abuse
• Previous bariatric surgery or device intervention for obesity

Other criteria may apply.

Compensation

Medication, office visits, dual energy X-ray absorptiometry (DEXA) scans, lab tests and compensation (patient stipend) are provided.

Location

Woman’s Hospital

100 Woman’s Way, Baton Rouge, LA 70817

Principal Investigator

Karen Elkind-Hirsch, PhD.

For further information

Visit Online: www.womans.org/about-womans/research
Call: (225) 231-5275

*Disclaimer

This study is not affiliated with PCOS Challenge, Inc. PCOS Challenge, Inc. does not recommend or endorse any specific studies, tests, physicians, products, procedures, opinions, or other information from third parties that may be mentioned on the PCOS Challenge websites. Any such mention is for information purposes only. Any third party services, products and websites, including those offered by affiliates, sponsors and advertisers, which may be accessed through the PCOS Challenge websites are the sole responsibility of the third party who is offering the service, product or posting the website. PCOS Challenge, Inc. makes no warranty as to the accuracy of any information on third party websites and accepts no liability for any claims, errors, and omissions or for any damage or injury to persons or property arising out of the use or operation of any services, products, materials, instructions, methods, ideas or procedures provided by third parties. Any offers, pricing, and/or promotions offered through the PCOS Challenge websites, affiliates, or any third party are subject change without notice at the sole discretion of the party making the offer. Read Full Disclaimer.